Story perspectives
Johnson & Johnson to Invest $1 Billion in PA Biomanufacturing Facility
2/19/2026
1 of 1
Story summary
- Johnson & Johnson announced a $1 billion investment to build a cell therapy manufacturing facility in Lower Gwynedd Township, Pennsylvania.
- The facility will create over 4,000 construction jobs and 500 skilled biomanufacturing positions, with completion expected in 2031.
- The project supports a $55 billion United States investment plan by 2029, with Pennsylvania providing $41.5 million in tax credits and grants.
